DRAFT-NOFO-720617-22-001: USAID Uganda Health Activity
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Uganda USAID-Kampala notices from 2022.
Uganda USAID-Kampala offered grants of up to $170 million to any type of organization. It expected to make $170 million in total. Applications closed on April 15, 2022.
From the official notice on Grants.gov, last changed April 4, 2022. Checked November 7, 2026.
- Award ceiling$170 million
- Total funding$170 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| 72061722RFA00003 | July 18, 2022 | Closed August 25, 2022 | Closed |
| RFI-720617-22-002 | December 13, 2021 | Closed January 24, 2022 | Closed |
Key dates
| Posted | April 4, 2022 |
|---|---|
| Deadline | April 15, 2022 |
| Archived by Grants.gov | May 15, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $170 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
To: All Interested Organizations Subject: Uganda Health Activity Draft Notice of Funding Opportunity (NOFO) The United States Government, represented by the U.S. Agency for International Development Mission in Uganda (USAID/Uganda), seeks to inform interested organizations of the release of the draft Notice of Funding Opportunity for the planned integrated health funding activity, titled the Uganda Health Activity. The proposed Uganda Health Activity aims to increase access to and use of quality healthcare services and improve the performance of the health system at subnational levels in priority districts. A draft NOFO is provided as Attachment 1. Interested organizations are invited to provide comments on the whole NOFO but with special emphasis on Section D – Application and Submission Information, Section E – Application Review Information, and Section F Federal Award Administration Information. The draft NOFO does NOT commit USAID to consider or incorporate any received comments, issue a Notice of Funding Opportunity or make an award on the basis of this draft NOFO. All response costs incurred in providing feedback to this NOFO are at the respondent’s expense. Please note that responding to this draft NOFO will not give any advantage to or preclude any organization or individual from responding to any Notice of Funding Opportunity (NOFO) that may be subsequently issued. If USAID releases a NOFO, it will be posted on www.grants.gov. It is the potential applicant’s responsibility to monitor these websites for the release of further information and updates. Applicants may submit up to three pages of responses or questions in Microsoft Word to this draft NOFO by email to kampalausaidsolicita@usaid.gov no later than the date and time shown below; Issuance Date: April 4, 2022 Response Due Date and Time: April 15, 2022, 5:00 p.m. Washington, D.C. time (EST) Response Email Address: kampalausaidsolicita@usaid.gov Do not submit any applications at this time. Information received in response to this draft NOFO will become the property of USAID. Therefore, information that cannot be shared should not be sent. Please note that respondents will not receive individualized feedback on their submission. USAID may revise the draft NOFO based on comments received but is not obligated to do so. Thank you for your interest in USAID programs and we look forward to receiving your feedback on the draft NOFO. See Attachment Tab for details.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is DRAFT-NOFO-720617-22-001 still open?
No. It closed on April 15, 2022.
Who can apply for USAID Uganda Health Activity?
Uganda USAID-Kampala accepted applications from any type of organization.
What is the deadline for USAID Uganda Health Activity?
Closed April 15, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $170 million each. About $170 million in total.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)